Browse the evidence

The digestibility of the encapsulated oleogel-in-oleogel system can be modulated by varying the ratio of its components.

This flexibility allows for the design of food products tailored to specific dietary needs.

GIPR activation influences energy balance and insulin sensitivity through mechanisms involving metabolic and thermogenic genes.

Understanding the molecular mechanisms of GIPR could inform strategies for improving insulin sensitivity.

New pharmacological molecules are likely to be treatment options for patients with rare genetic obesities in the coming years.

Practitioners should stay informed about emerging pharmacological treatments for obesity.

The positioning of new therapeutics in the management of rare genetic obesities needs to be well defined.

Clinicians should consider how to integrate new therapeutics into treatment plans for obesity.

Polymeric biomaterials have gained tremendous interest for their potential in the prevention and treatment of obesity.

Practitioners should consider polymeric biomaterials as a promising avenue for obesity treatment.

Recent studies have identified new genetic regulatory mechanisms and potential biomarker regions for the POMC gene and MC4R secondary messenger pathway associated with obesity.

These findings may lead to new diagnostic tools for obesity.

The compounds K2 and K5 modify CCK1 activity by preventing/hindering interactions between CCK peptides and CCK1.

Understanding how K2 and K5 interact with CCK1 can guide drug development.

Recent studies support the plausibility and evidence of individual nutritional measures for dyslipidemias.

Practitioners should stay updated on recent studies regarding nutritional interventions for dyslipidemias.

Exercise may improve glycemic control through key cellular and molecular adaptive processes.

Practitioners should consider the types of exercise that promote these adaptive processes for better glycemic control.

Mendelian randomisation awaits confirmation with RCT and real-world data.

Further research is needed to confirm the findings regarding GLP-1RA and suicide attempts.